Soleno Therapeutics Inc (SLNO) — Long-term Investment Intensity
Soleno Therapeutics Inc (SLNO) has a Long-term Investment Intensity of 35.6% as of December 2025. Long-term investments of $200.62 Million represent 35.6% of total assets of $563.83 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check financial resilience of Soleno Therapeutics Inc to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Soleno Therapeutics Inc Long-term Investment Intensity (2024–2025)
This chart shows how Soleno Therapeutics Inc's Long-term Investment Intensity has evolved across 2 annual periods from 2024 to 2025. As of December 2025, the intensity stands at 35.6%, reflecting long-term investments of $200.62 Million against total assets of $563.83 Million USD. For the complete balance sheet picture, see SLNO asset base.
Annual Long-term Investment Intensity for Soleno Therapeutics Inc (2024–2025)
The table below presents the year-by-year Long-term Investment Intensity for Soleno Therapeutics Inc from 2024 to 2025, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read Soleno Therapeutics Inc (SLNO) financial obligations for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 35.6% | $200.62 Million | $563.83 Million | ▲ +27.4 pp |
| 2024 | 8.2% | $27.21 Million | $330.97 Million | — |